No Association Between COVID-19 Antiviral Drug, Illness Rebound, FDA Report Says

ABC News (3/15, Flaherty, Westman) reports an FDA “analysis did not find a clear association between the COVID-19 antiviral drug Paxlovid [nirmatrelvir/ritonavir] and illness rebound, the FDA said in a new report.” Rebound rates are roughly “the same in p...